溶性尿素酶类型等离子素激活受体在心血管疾病中的作用
1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, 1500 E Medical Center Dr, CVC #2709, Ann Arbor, 48109, MI, USA.
Current cardiology reports
|November 10, 2023
概括
溶性泌尿酸酶等离子体激活受体 (suPAR) 通过影响免疫细胞功能驱动动动脉硬化. 测量suPAR可以改善心血管疾病风险预测,并指导新的针对炎症的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 生物标志物研究 生物标志物研究
背景情况:
- 慢性炎症显著增加了心血管疾病 (CVD) 的风险.
- 溶性泌尿酸酶等离子体激活受体 (suPAR),一种免疫衍生的糖蛋白,与动脉样硬化疾病有关.
研究的目的:
- 审查suPAR在心血管疾病发病过程中的作用.
- 探索suPAR作为预后指标和治疗目标的潜力.
主要方法:
- 对临床,遗传和实验证据的审查.
- 分析suPAR对单细胞激活和功能的影响.
- 检查suPAR水平与心血管风险之间的临床关联.
主要成果:
- suPAR作为动脉样硬化的致病因子,调节髓状细胞功能,促进血管炎症.
- 较高的suPAR水平与不同人群中心血管风险增加有关.
- 临床试验正在研究针对suPAR的治疗方法.
结论:
- suPAR是免疫细胞功能的关键调节者,有助于心血管疾病.
- suPAR是预测心血管疾病风险和个性化管理的有希望的生物标志物.
- 针对suPAR提供了一种潜在的降低炎症和心血管风险的策略.
相关概念视频
01:16Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:22Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
01:30Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
535
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
535